Deficiency Letters (Ordinario de Completitud): Response Strategy for Chile

1. Key takeaways

If the ISP identifies gaps in the dossier during review, it issues a deficiency notice (ordinario de completitud). Under Chile’s administrative procedures law, Ley N° 19.880, the response period is short (in practice, commonly handled as 5 business days). A deficiency is not a second chance; it is an interruption that costs weeks. The review clock effectively pauses while the applicant scrambles to locate, correct, re-authenticate and re-translate documents, and the queue position earned by an early filing erodes with every day the response takes.

The GRZAN principle: prepare the first submission to a zero-deficiency standard. Under a document-review regime, the ISP does not repeat testing, so review quality depends entirely on how the dossier is organized and how complete it is. Every hour invested in a pre-submission internal review is repaid many times over in avoided deficiency cycles, because a deficiency cycle costs not just the response window but the momentum of the entire submission. The goal is a dossier that answers every foreseeable question before the reviewer asks it. The notice itself is routine; the danger lies in what its arrival does to the project calendar and to the queue. The zero-deficiency standard is achievable because the recurring causes are finite and mechanical.

2. Legal basis

The following sources govern deficiency notices, response periods and the related appeal timelines:

• Basic law on administrative procedures | Ley N° 19.880, de 2003 | 2003 | the system of deficiency requests, notifications and procedural deadlines for administrative bodies.
• ISP procedure | prestación 9100003 (v3, September 25, 2025) | a deficiency notice (ordinario de completitud) may be issued during review; the response period is short (in practice about 5 business days, governed by what the notice states).
• Regulation on the control of pharmaceutical products and medical devices | Decreto Supremo N° 825, de 1998 | August 21, 1999 | Article 21: documentation requirements by category; Article 6: 15 business days to appeal a nonconformity finding; Article 7: the institution concerned must respond within 10 business days.
• Sanitary Code of Chile (Código Sanitario) | DFL N° 725, de 1967 | Article 111(b) | cases where the ISP performs the verification itself (the deficiency notice is issued by the ISP directly).

3. Expert insights

Insight 1: the deficiency response period runs in business days, counted from arrival of the notice.

5 business days (practical estimate) means that cross-time-zone communication, internal review and re-authentication are practically impossible within the window. The only thing a company can do is make the first submission not need a deficiency at all. By the time the notice arrives, the strategy has already failed; the remaining question is only how much queue position the failure costs. This is why the zero-deficiency standard is a submission-stage discipline, not a response-stage virtue: the response stage is damage control by definition. A notice received on a Friday effectively consumes the weekend, and the internal escalation begins before any substance is reviewed.

Insight 2: deficiencies cluster into three high-frequency causes.

GRZAN’s tally of high-frequency causes identifies three: inconsistent product information (names and models do not match across the CFS, the power of attorney, the labels and the technical file), missing authentication (the CFS, power of attorney or quality system certificate never completed the Apostille), and missing standards mapping (test reports not mapped to NCh or other applicable Chilean standards). All three can be caught by self-checks before submission. None of them requires new data, new testing or authority discretion; each is a mechanical consistency check that a pre-submission checklist catches in an afternoon. Assigning each check to a named owner before submission turns the self-check from good intention into a gate.

Insight 3: the review clock effectively pauses during the deficiency period.

Once the deficiency notice issues, review waits for the applicant’s response. During that pause, the queue position can be overtaken by later filers, especially during the submission peak expected in 2027–2028. An early filing that triggers a deficiency can therefore end up reviewing later than a later filing that was complete, which inverts the whole logic of filing early. The pause is also invisible in the ISP timeline, which is why teams underestimate its cost until the certificate arrives late. The queue is not a waiting room with reserved seats; it rewards whoever keeps a complete, moving file.

Insight 4: distinguish a deficiency from a nonconformity.

A deficiency is a documentation gap (the subject of this article); a nonconformity is a verification conclusion, appealable within 15 business days under Article 6 of Decreto Supremo N° 825, de 1998. The response paths are completely different: the former is cured by supplying or correcting documents, the latter by initiating an appeal procedure. Treating a nonconformity as a deficiency wastes the appeal window, and treating a deficiency as a nonconformity escalates a routine paperwork fix into an unnecessary formal dispute. Classifying each notice correctly on the day it arrives is therefore the first step of the response workflow.

4. Practical recommendations

1. Run the pre-submission internal review to a zero-deficiency standard, using the three high-frequency causes as the self-check list.
2. Verify product information word by word across the four documents: the CFS, the power of attorney, the labels and the technical file.
3. Complete the Apostille list in one round: CFS, manufacturer authorization letter, quality system certificate, sterile batch certificate.
4. Build an NCh standards mapping for the test reports, with an explanatory note.
5. Pre-establish a rapid response mechanism for deficiency notices: authorize the Chilean license holder to receive and forward the notice the same day, shortening internal transmission time.

5. Verification checklist

• □ The pre-submission internal review has been completed to a zero-deficiency standard
• □ Product information is word-for-word identical across the CFS, power of attorney, labels and technical file
• □ The Apostille list is complete (CFS, authorization letter, system certificate, sterile batch certificate)
• □ An NCh standards mapping has been built for the test reports
• □ A same-day forwarding mechanism for deficiency notices is in place

Regulatory information verified as of October 29, 2026.

GRZAN supports medical device manufacturers entering the Chilean market with end-to-end services covering the local license holder and importer setup, zero-deficiency dossier preparation and deficiency notice handling, and fee and budget planning under the current ISP arancel. Whether you need a pre-submission review, a cost model for your product class, or hands-on filing support through GICONA, our regulatory team is ready to help. Contact us at info@grzanglobal.com.